North Crest Asset Manangement, LLC Biomarin Pharmaceutical Inc Transaction History
North Crest Asset Manangement, LLC
- $3.54 Billion
- Q2 2025
A detailed history of North Crest Asset Manangement, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, North Crest Asset Manangement, LLC holds 3,507 shares of BMRN stock, worth $209,262. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,507
Previous 4,885
28.21%
Holding current value
$209,262
Previous $345,000
44.35%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding BMRN
# of Institutions
665Shares Held
184MCall Options Held
1.24MPut Options Held
957K-
Black Rock Inc. New York, NY22.7MShares$1.36 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.13 Billion0.03% of portfolio
-
Primecap Management CO Pasadena, CA17.8MShares$1.06 Billion1.06% of portfolio
-
Dodge & Cox San Francisco, CA15MShares$892 Million0.65% of portfolio
-
Viking Global Investors LP10.8MShares$644 Million2.55% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $11.1B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...